Leflunomide is used for: Rheumatoid arthritis; Psoriatic arthritis.
Recorded in the NepalDoc medicine catalog for Leflunomide.
Leflunomide Tablets, USP are indicated for the treatment of adults with active rheumatoid arthritis (RA).
From the U.S. FDA-approved label for Leflunomide. Full label: DailyMed.
Leflunomide Tablets, USP are indicated for the treatment of adults with active rheumatoid arthritis (RA).
From the U.S. FDA-approved label for Leflunomide. Full label: DailyMed.
Loading dosage for patients at low risk for leflunomide -associated hepatotoxicity and leflunomide -associated myelosuppression: 100 mg daily for 3 days. Maintenance dosage: 20 mg daily. Maximum recommended daily dosage: 20 mg once daily.
Directions from the U.S. FDA-approved label for Leflunomide — your doctor or pharmacist may advise differently.
Leflunomide tablets are contraindicated in: Pregnant women. Leflunomide may cause fetal harm. If a woman becomes pregnant while taking this drug, stop leflunomide, apprise the patient of the potential hazard to the fetus, and begin a drug elimination procedure. Patients with severe hepatic impairment. Patients with known hypersensitivity to leflunomide or any of the other components of leflunomide tablets. Known reactions include anaphylaxis. Patients being treated with teriflunomide. Severe hepatic impairment.
Excerpt from the U.S. FDA-approved label for Leflunomide. Talk to a pharmacist or doctor before use.
After stopping leflunomide, it is recommended that an accelerated drug elimination procedure be used to reduce the plasma concentrations of the active metabolite, teriflunomide. Severe infections (including sepsis), pancytopenia, agranulocytosis and thrombocytopenia: Stop leflunomide and use accelerated elimination procedure. Do not start leflunomide in patients with active infection. Monitor CBCs during treatment with leflunomide. Stevens-Johnson syndrome and toxic epidermal necrolysis: Stop leflunomide and use accelerated elimination procedure.
Warnings and precautions excerpt from the U.S. FDA-approved label for Leflunomide — not a complete list. Talk to a pharmacist or doctor before use.
The following serious adverse reactions are described elsewhere in the labeling: Hepatotoxicity Immunosuppression Bone marrow suppression Stevens-Johnson syndrome and toxic epidermal necrolysis Peripheral neuropathy Interstitial lung disease The most commonly reported adverse reactions (≥10%) regardless of relation to leflunomide treatment were diarrhea, respiratory infection, nausea, headache, rash, abnormal liver enzymes,…
Excerpt from the U.S. FDA-approved label for Leflunomide — not a complete list. Talk to a pharmacist or doctor about side effects.
21 brands · 12 makers in the NepalDoc catalog — see the full Leflunomide guide →
Store at 25°C (77°F); Protect from light.
Storage information from the U.S. FDA-approved label for Leflunomide.
What is RUMALEF?
RUMALEF 20MG Tablet is a Leflunomide medicine made by Vega Pharma. It comes as 20MG Tablet.
What is RUMALEF used for?
Leflunomide is used for Rheumatoid arthritis, Psoriatic arthritis.
What is the generic name of RUMALEF?
The generic name of RUMALEF is Leflunomide.
Which brands of Leflunomide are available in Nepal?
21 brands of Leflunomide are listed in the NepalDoc catalog, from 12 makers — including Arava 10mg Tablet, Arava 100mg Tablet, Arava 20mg Tablet, Imulef 20mg Tablet, Imulef 10mg Tablet, Leflu 10mg Tablet.
What are the side effects of Leflunomide?
The following serious adverse reactions are described elsewhere in the labeling: Hepatotoxicity Immunosuppression Bone marrow suppression Stevens-Johnson syndrome and toxic epidermal necrolysis Peripheral neuropathy Interstitial lung disease The most commonly reported adverse reactions (≥10%) regardless of relation to leflunomide treatment were diarrhea, respiratory infection, nausea, headache, rash, abnormal liver enzymes,…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
